Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review THM Moore, S Zammit, A Lingford-Hughes, TRE Barnes, PB Jones, ... The Lancet 370 (9584), 319-328, 2007 | 2995 | 2007 |
Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review M Marshall, S Lewis, A Lockwood, R Drake, P Jones, T Croudace Archives of general psychiatry 62 (9), 975-983, 2005 | 2068 | 2005 |
Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort P Jones, R Murray, B Rodgers, M Marmot The Lancet 344 (8934), 1398-1402, 1994 | 1868 | 1994 |
Obstetric complications and schizophrenia: historical and meta-analytic review M Cannon, PB Jones, RM Murray American Journal of Psychiatry 159 (7), 1080-1092, 2002 | 1722 | 2002 |
Randomized controlled trial of the effect on Quality of Life of second-vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs … PB Jones, TRE Barnes, L Davies, G Dunn, H Lloyd, KP Hayhurst, ... Archives of general psychiatry 63 (10), 1079-1087, 2006 | 1586 | 2006 |
Oligodendrocyte dysfunction in schizophrenia and bipolar disorder D Tkachev, ML Mimmack, MM Ryan, M Wayland, T Freeman, PB Jones, ... The Lancet 362 (9386), 798-805, 2003 | 1070 | 2003 |
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment GM Khandaker, L Cousins, J Deakin, BR Lennox, R Yolken, PB Jones The Lancet Psychiatry 2 (3), 258-270, 2015 | 920 | 2015 |
Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study GM Khandaker, RM Pearson, S Zammit, G Lewis, PB Jones JAMA psychiatry 71 (10), 1121-1128, 2014 | 888 | 2014 |
Adult mental health disorders and their age at onset PB Jones The British journal of psychiatry 202 (s54), s5-s10, 2013 | 866 | 2013 |
The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study M Di Forti, D Quattrone, TP Freeman, G Tripoli, C Gayer-Anderson, ... The Lancet Psychiatry 6 (5), 427-436, 2019 | 832 | 2019 |
The Clinical Global Impression–Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia JM Haro, SA Kamath, SO Ochoa, D Novick, K Rele, A Fargas, ... Acta Psychiatrica Scandinavica 107, 16-23, 2003 | 766 | 2003 |
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study JB Kirkbride, P Fearon, C Morgan, P Dazzan, K Morgan, J Tarrant, T Lloyd, ... Archives of general psychiatry 63 (3), 250-258, 2006 | 749 | 2006 |
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study P Fearon, JB Kirkbride, C Morgan, P Dazzan, K Morgan, T Lloyd, ... Psychological medicine 36 (11), 1541-1550, 2006 | 719 | 2006 |
Incidence of schizophrenia and other psychoses in England, 1950–2009: a systematic review and meta-analyses JB Kirkbride, A Errazuriz, TJ Croudace, C Morgan, D Jackson, J Boydell, ... PloS one 7 (3), e31660, 2012 | 677 | 2012 |
Schizophrenia as a long-term outcome of pregnancy, delivery, and perinatal complications: a 28-year follow-up of the 1966 north Finland general population birth cohort PB Jones, P Rantakallio, AL Hartikainen, M Isohanni, P Sipila American Journal of Psychiatry 155 (3), 355-364, 1998 | 650 | 1998 |
Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions N Kappelmann, G Lewis, R Dantzer, PB Jones, GM Khandaker Molecular psychiatry 23 (2), 335-343, 2018 | 635 | 2018 |
Substantia nigra/ventral tegmental reward prediction error disruption in psychosis GK Murray, PR Corlett, L Clark, M Pessiglione, AD Blackwell, G Honey, ... Molecular psychiatry 13 (3), 267-276, 2008 | 607 | 2008 |
A mindfulness-based intervention to increase resilience to stress in university students (the Mindful Student Study): a pragmatic randomised controlled trial J Galante, G Dufour, M Vainre, AP Wagner, J Stochl, A Benton, N Lathia, ... The Lancet Public Health 3 (2), e72-e81, 2018 | 590 | 2018 |
Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels EF Osimo, LJ Baxter, G Lewis, PB Jones, GM Khandaker Psychological medicine 49 (12), 1958-1970, 2019 | 581 | 2019 |
Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia SW Lewis, TRE Barnes, L Davies, RM Murray, G Dunn, KP Hayhurst, ... Schizophrenia bulletin 32 (4), 715-723, 2006 | 547 | 2006 |